Cargando…

A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life

INTRODUCTION: In persons with type 1 diabetes (T1D) insulin dosing can be adjusted based on trend arrows derived from continuous glucose monitoring (CGM). We propose a slide rule with narrower blood glucose intervals and more classes of insulin sensitivity than are available in current models. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruttomesso, Daniela, Boscari, Federico, Lepore, Giuseppe, Noaro, Giulia, Cappon, Giacomo, Girelli, Angela, Bozzetto, Lutgarda, Tumminia, Andrea, Grassi, Giorgio, Sparacino, Giovanni, Laviola, Luigi, Facchinetti, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099956/
https://www.ncbi.nlm.nih.gov/pubmed/33725276
http://dx.doi.org/10.1007/s13300-021-01020-2
_version_ 1783688678616334336
author Bruttomesso, Daniela
Boscari, Federico
Lepore, Giuseppe
Noaro, Giulia
Cappon, Giacomo
Girelli, Angela
Bozzetto, Lutgarda
Tumminia, Andrea
Grassi, Giorgio
Sparacino, Giovanni
Laviola, Luigi
Facchinetti, Andrea
author_facet Bruttomesso, Daniela
Boscari, Federico
Lepore, Giuseppe
Noaro, Giulia
Cappon, Giacomo
Girelli, Angela
Bozzetto, Lutgarda
Tumminia, Andrea
Grassi, Giorgio
Sparacino, Giovanni
Laviola, Luigi
Facchinetti, Andrea
author_sort Bruttomesso, Daniela
collection PubMed
description INTRODUCTION: In persons with type 1 diabetes (T1D) insulin dosing can be adjusted based on trend arrows derived from continuous glucose monitoring (CGM). We propose a slide rule with narrower blood glucose intervals and more classes of insulin sensitivity than are available in current models. METHODS: The slide rule was tested in silico, in which a meal was simulated in 100 virtual subjects and the insulin bolus was calculated either in the standard way based on the insulin-to-carbohydrate ratio and the correction factor or according to the slide rule, following which the percentage time spent in range (70–180 mg/dl; %T(IR)), hypoglycemia (< 70 mg/dl; %T(HYPO)), and hyperglycemia (> 180 mg/dl; %T(HYPER)) was compared between the methods during the 4 h after the meal. Slide rule performance was also tested in real life by analyzing the same variables at during the 4 h postprandial period in 27 individuals with T1D. Only meals starting while the rate of change was at least 1 mg/dl per minute (increasing or decreasing) were considered for analysis. RESULTS: In silico, when the preprandial trend arrow was increasing, our slide rule reduced %T(HYPER) and increased %T(IR) (p < 0.05), whereas when the preprandial trend arrow was decreasing, it reduced %T(HYPO) and slightly increased %T(HYPER) (p < 0.05). In real life, our slide rule kept subjects on target for 70.8 and 91.6% of postprandial time when preprandial trend arrows were increasing or decreasing, respectively. CONCLUSION: The proposed slide rule performed well both in silico and in real life, suggesting that it could be safely adopted by individuals with T1D to improve glucose control.
format Online
Article
Text
id pubmed-8099956
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-80999562021-05-11 A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life Bruttomesso, Daniela Boscari, Federico Lepore, Giuseppe Noaro, Giulia Cappon, Giacomo Girelli, Angela Bozzetto, Lutgarda Tumminia, Andrea Grassi, Giorgio Sparacino, Giovanni Laviola, Luigi Facchinetti, Andrea Diabetes Ther Original Research INTRODUCTION: In persons with type 1 diabetes (T1D) insulin dosing can be adjusted based on trend arrows derived from continuous glucose monitoring (CGM). We propose a slide rule with narrower blood glucose intervals and more classes of insulin sensitivity than are available in current models. METHODS: The slide rule was tested in silico, in which a meal was simulated in 100 virtual subjects and the insulin bolus was calculated either in the standard way based on the insulin-to-carbohydrate ratio and the correction factor or according to the slide rule, following which the percentage time spent in range (70–180 mg/dl; %T(IR)), hypoglycemia (< 70 mg/dl; %T(HYPO)), and hyperglycemia (> 180 mg/dl; %T(HYPER)) was compared between the methods during the 4 h after the meal. Slide rule performance was also tested in real life by analyzing the same variables at during the 4 h postprandial period in 27 individuals with T1D. Only meals starting while the rate of change was at least 1 mg/dl per minute (increasing or decreasing) were considered for analysis. RESULTS: In silico, when the preprandial trend arrow was increasing, our slide rule reduced %T(HYPER) and increased %T(IR) (p < 0.05), whereas when the preprandial trend arrow was decreasing, it reduced %T(HYPO) and slightly increased %T(HYPER) (p < 0.05). In real life, our slide rule kept subjects on target for 70.8 and 91.6% of postprandial time when preprandial trend arrows were increasing or decreasing, respectively. CONCLUSION: The proposed slide rule performed well both in silico and in real life, suggesting that it could be safely adopted by individuals with T1D to improve glucose control. Springer Healthcare 2021-03-16 2021-05 /pmc/articles/PMC8099956/ /pubmed/33725276 http://dx.doi.org/10.1007/s13300-021-01020-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Bruttomesso, Daniela
Boscari, Federico
Lepore, Giuseppe
Noaro, Giulia
Cappon, Giacomo
Girelli, Angela
Bozzetto, Lutgarda
Tumminia, Andrea
Grassi, Giorgio
Sparacino, Giovanni
Laviola, Luigi
Facchinetti, Andrea
A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life
title A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life
title_full A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life
title_fullStr A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life
title_full_unstemmed A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life
title_short A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life
title_sort “slide rule” to adjust insulin dose using trend arrows in adults with type 1 diabetes: test in silico and in real life
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099956/
https://www.ncbi.nlm.nih.gov/pubmed/33725276
http://dx.doi.org/10.1007/s13300-021-01020-2
work_keys_str_mv AT bruttomessodaniela aslideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT boscarifederico aslideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT leporegiuseppe aslideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT noarogiulia aslideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT cappongiacomo aslideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT girelliangela aslideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT bozzettolutgarda aslideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT tumminiaandrea aslideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT grassigiorgio aslideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT sparacinogiovanni aslideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT laviolaluigi aslideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT facchinettiandrea aslideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT bruttomessodaniela slideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT boscarifederico slideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT leporegiuseppe slideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT noarogiulia slideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT cappongiacomo slideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT girelliangela slideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT bozzettolutgarda slideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT tumminiaandrea slideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT grassigiorgio slideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT sparacinogiovanni slideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT laviolaluigi slideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife
AT facchinettiandrea slideruletoadjustinsulindoseusingtrendarrowsinadultswithtype1diabetestestinsilicoandinreallife